Tech Company Financing Transactions
Gleamer Funding Round
On 6/28/2023, Gleamer raised $29.5 million in Series B funding from Supernova Invest, Bpifrance and Crista Galli Ventures.
Transaction Overview
Company Name
Announced On
6/28/2023
Transaction Type
Venture Equity
Amount
$29,500,000
Round
Series B
Investors
Proceeds Purpose
Gleamer, a five-year-old French startup that has developed AI software to help radiologists diagnose and detect bone trauma lesions in scans, among other conditions, has raised �27 million ($29.5 million) in a Series B round of funding.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
185 Alewife Brook Parkway 210
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Undisclosed
Website
Email Address
Overview
Bringing together the best of Humans and Technology to serve patients across the globe. We want to companion imaging users with a suite of Artificial Intelligence solutions covering a wide range of clinical applications. We are passionate about solving challenging medical problems with multidisciplinary teams and creating constructive environments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christian Allouche
Chief Financial Officer
Noé Poyet
Chief Medical Officer
Nor-Eddine Regnard
Chief Technical Officer
Alexis Ducarouge
Browse more venture capital transactions:
Prev: 6/28/2023: OnSyte Performance venture capital transaction
Next: 6/28/2023: Author Health venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs